Literature DB >> 35148234

Trypsin cleavage of the β1-adrenergic receptor.

Jing Zhu1, Susan F Steinberg1.   

Abstract

β1-Adrenergic receptors (β1ARs) are the principal mediators of catecholamine action in cardiomyocytes. We previously showed that β1ARs accumulate as both full-length and NH2-terminally truncated species in cells, that maturational processing of full-length β1ARs to an NH2-terminally truncated form is attributable to O-glycan-regulated proteolytic cleavage of the β1AR NH2-terminus at R31 ↓ L32 by ADAM17, and that NH2-terminally truncated β1ARs remain signaling competent but they acquire a distinct signaling phenotype. NH2-terminally truncated β1ARs differ from full-length β1ARs in their signaling bias to cAMP/PKA versus ERK pathways and only the NH2-terminally truncated form of the β1AR constitutively activates AKT and confers protection against doxorubicin-dependent apoptosis in cardiomyocytes. Since the R31 ↓ L32 sequence conforms to a trypsin consensus cleavage site, we used immunoblotting methods to test the hypothesis that β1ARs are also cleaved at R31 ↓ L32 by trypsin (an enzyme typically used to isolate cardiomyocytes from the intact ventricle). We show that full-length β1ARs are cleaved by trypsin and that trypsin cleaves the full-length β1AR NH2-terminus specifically at R31 ↓ L32 in CHO-Pro5 cells. Trypsin also cleaves β1ARs in cardiomyocytes, but at a second site that results in the formation of ∼40-kDa NH2-terminal and ∼30-kDa COOH-terminal fragments. The observation that cardiomyocyte β1ARs are cleaved by trypsin (a mechanism that constitutes a heretofore-unrecognized mechanism that would influence β1AR-signaling responses) suggests that studies that use standard trypsin-based procedures to isolate adult cardiomyocytes from the intact ventricle should be interpreted with caution.NEW & NOTEWORTHY Current concepts regarding the molecular basis for β1AR responses derive from literature predicated on the assumption that β1ARs signal exclusively as full-length receptor proteins. However, we recently showed that β1ARs accumulate as both full-length and NH2-terminally truncated forms. This manuscript provides novel evidence that β1-adrenergic receptors can be cleaved by trypsin and that cell surface β1AR cleavage constitutes a heretofore unrecognized mechanism to alter catecholamine-dependent signaling responses.

Entities:  

Keywords:  cardiomyocytes; trypsin; β1-adrenergic receptors

Mesh:

Substances:

Year:  2022        PMID: 35148234      PMCID: PMC8897006          DOI: 10.1152/ajpheart.00005.2022

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

Review 1.  Lifting the lid on GPCRs: the role of extracellular loops.

Authors:  M Wheatley; D Wootten; M T Conner; J Simms; R Kendrick; R T Logan; D R Poyner; J Barwell
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  The G protein-coupled receptor N-terminus and receptor signalling: N-tering a new era.

Authors:  James L J Coleman; Tony Ngo; Nicola J Smith
Journal:  Cell Signal       Date:  2017-02-08       Impact factor: 4.315

3.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

4.  Site-specific O-Glycosylation by Polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates β1-Adrenergic Receptor N-terminal Cleavage.

Authors:  Christoffer K Goth; Hanna E Tuhkanen; Hamayun Khan; Jarkko J Lackman; Shengjun Wang; Yoshiki Narimatsu; Lasse H Hansen; Christopher M Overall; Henrik Clausen; Katrine T Schjoldager; Ulla E Petäjä-Repo
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

5.  β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitro.

Authors:  Anna E Hakalahti; Hamayun Khan; Miia M Vierimaa; Emilia H Pekkala; Jarkko J Lackman; Johanna Ulvila; Risto Kerkelä; Ulla E Petäjä-Repo
Journal:  Mol Pharmacol       Date:  2012-10-11       Impact factor: 4.436

6.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

7.  Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.

Authors:  Beihua Zhong; Donna H Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-07       Impact factor: 3.619

8.  β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors.

Authors:  Jing Zhu; Susan F Steinberg
Journal:  J Mol Cell Cardiol       Date:  2021-02-06       Impact factor: 5.000

9.  β1-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes.

Authors:  Misun Park; Gopireddy R Reddy; Gerd Wallukat; Yang K Xiang; Susan F Steinberg
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

10.  Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β1-Adrenergic Receptors.

Authors:  Misun Park; Susan F Steinberg
Journal:  JACC Basic Transl Sci       Date:  2018-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.